134 related articles for article (PubMed ID: 8796324)
21. Stabilizing the subtilisin BPN' pro-domain by phage display selection: how restrictive is the amino acid code for maximum protein stability?
Ruan B; Hoskins J; Wang L; Bryan PN
Protein Sci; 1998 Nov; 7(11):2345-53. PubMed ID: 9828000
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
Kojima S; Nishiyama Y; Kumagai I; Miura K
J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
[TBL] [Abstract][Full Text] [Related]
23. Folding of subtilisin BPN': characterization of a folding intermediate.
Eder J; Rheinnecker M; Fersht AR
Biochemistry; 1993 Jan; 32(1):18-26. PubMed ID: 8418836
[TBL] [Abstract][Full Text] [Related]
24. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content.
Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG
J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655
[TBL] [Abstract][Full Text] [Related]
26. Protein engineering of subtilisin BPN': enhanced stabilization through the introduction of two cysteines to form a disulfide bond.
Pantoliano MW; Ladner RC; Bryan PN; Rollence ML; Wood JF; Poulos TL
Biochemistry; 1987 Apr; 26(8):2077-82. PubMed ID: 3476160
[TBL] [Abstract][Full Text] [Related]
27. Improvement of a useful enzyme (subtilisin BPN') by an experimental evolution system.
Tange T; Taguchi S; Kojima S; Miura K; Momose H
Appl Microbiol Biotechnol; 1994 Apr; 41(2):239-44. PubMed ID: 7764834
[TBL] [Abstract][Full Text] [Related]
28. The crystal structure of an autoprocessed Ser221Cys-subtilisin E-propeptide complex at 2.0 A resolution.
Jain SC; Shinde U; Li Y; Inouye M; Berman HM
J Mol Biol; 1998 Nov; 284(1):137-44. PubMed ID: 9811547
[TBL] [Abstract][Full Text] [Related]
29. Proteases of enhanced stability: characterization of a thermostable variant of subtilisin.
Bryan PN; Rollence ML; Pantoliano MW; Wood J; Finzel BC; Gilliland GL; Howard AJ; Poulos TL
Proteins; 1986 Dec; 1(4):326-34. PubMed ID: 3329733
[TBL] [Abstract][Full Text] [Related]
30. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
[TBL] [Abstract][Full Text] [Related]
31. Free energy perturbation techniques applied to subtilisin BPN' stability.
Barnett BL; Turner CB
Adv Exp Med Biol; 1996; 379():121-31. PubMed ID: 8796316
[TBL] [Abstract][Full Text] [Related]
32. The engineering of binding affinity at metal ion binding sites for the stabilization of proteins: subtilisin as a test case.
Pantoliano MW; Whitlow M; Wood JF; Rollence ML; Finzel BC; Gilliland GL; Poulos TL; Bryan PN
Biochemistry; 1988 Nov; 27(22):8311-7. PubMed ID: 3072018
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin.
Takeuchi Y; Nonaka T; Nakamura KT; Kojima S; Miura K; Mitsui Y
Proc Natl Acad Sci U S A; 1992 May; 89(10):4407-11. PubMed ID: 1584773
[TBL] [Abstract][Full Text] [Related]
34. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
Kojima S; Minagawa T; Miura K
FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of subtilisin BPN' variants containing disulfide bonds and cavities: concerted structural rearrangements induced by mutagenesis.
Katz B; Kossiakoff AA
Proteins; 1990; 7(4):343-57. PubMed ID: 2199972
[TBL] [Abstract][Full Text] [Related]
36. Enzyme behavior at surfaces. Site-specific variants of subtilisin BPN' with enhanced surface stability.
Brode PF; Erwin CR; Rauch DS; Lucas DS; Rubingh DN
J Biol Chem; 1994 Sep; 269(38):23538-43. PubMed ID: 8089121
[TBL] [Abstract][Full Text] [Related]
37. X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition state.
Matthews DA; Alden RA; Birktoft JJ; Freer ST; Kraut J
J Biol Chem; 1975 Sep; 250(18):7120-6. PubMed ID: 1165237
[TBL] [Abstract][Full Text] [Related]
38. The crystal structure of the Bacillus lentus alkaline protease, subtilisin BL, at 1.4 A resolution.
Goddette DW; Paech C; Yang SS; Mielenz JR; Bystroff C; Wilke ME; Fletterick RJ
J Mol Biol; 1992 Nov; 228(2):580-95. PubMed ID: 1453465
[TBL] [Abstract][Full Text] [Related]
39. Calcium-independent subtilisin by design.
Gallagher T; Bryan P; Gilliland GL
Proteins; 1993 Jun; 16(2):205-13. PubMed ID: 8332608
[TBL] [Abstract][Full Text] [Related]
40. The interaction of a tyrosyl residue and carboxyl groups in the specific interaction between Streptomyces subtilisin inhibitor and subtilisin BPN'. A chemical modification study.
Inouye K; Tonomura B; Hiromi K
J Biochem; 1979 May; 85(5):1115-26. PubMed ID: 447612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
